Oral progestins achieved a nearly 90% success rate in reducing or stopping heavy menstrual bleeding among adolescent and young adult females with bleeding disorders, according to a study published in the Journal of Adolescent Health. The findings suggest these medications outperformed four other treatment methods evaluated by researchers. The retrospective study, led by He Huang, … Read more
Vaginal births saw a relative reduction in postpartum hemorrhage of approximately 40% after a hospital doubled the dose of oxytocin administered during the first hour after delivery, according to a Michigan Medicine-led study. The research, published in Obstetrics & Gynecology, The Green Journal, found that increasing the dose from 30 units to 60 units significantly … Read more
Led by researchers from McMaster University, an analysis of over one million births discovered that putting on too much weight throughout pregnancy is connected to an elevated danger of life-threatening maternal complications, regardless of the individual’s initial weight. McMaster University Researchers Analyze Over One Million Births Published on Oct. 22, 2026, in JAMA Network Open, … Read more
Acute kidney injury affects up to 60 percent of intensive care patients worldwide, presenting a major challenge for critical care medicine that now has standardized clinical guidance. According to the Journal of Intensive Medicine, a multidisciplinary expert panel organized by the Chinese Society of Critical Care Medicine published comprehensive guidelines on August 18, 2026, establishing … Read more
According to the European Society of Cardiology, non-vitamin K antagonist oral anticoagulant (NOAC) therapy reduces imaging signs of clot formation on new heart valves by 45% compared with antiplatelet therapy following transcatheter aortic valve implantation (TAVI), without compromising patient safety. ACASA-TAVI Trial Results Presented at ESC Congress 2026 The ACASA-TAVI trial, presented during a Hot … Read more
A TAVI-first strategy for patients with severe aortic stenosis and concomitant coronary artery disease is noninferior to a PCI-first approach at one year, according to clinical trial results presented at the ESC Congress 2026 and published simultaneously in the New England Journal of Medicine. Researchers evaluated 986 patients across 48 centers to compare the competing … Read more
According to results presented at the ESC Congress and published in the New England Journal of Medicine, prasugrel reduced major cardiovascular events to the same extent as ticagrelor while lowering major bleeding risks after coronary stenting in patients with acute coronary syndromes. The registry-based SWITCH SWEDEHEART trial evaluated 17,095 consecutive adults undergoing percutaneous coronary intervention … Read more
A study published this month in the Journal of the American Veterinary Medical Association reports that cumulative omeprazole use in racehorses is linked to a modest increase in the incidence of exercise-induced pulmonary hemorrhaging (EIPH). Researchers analyzing Hong Kong racing records estimated that an 11% reduction in EIPH cases could theoretically occur if omeprazole administration … Read more
The updated ABCs of cardiovascular disease (CVD) prevention framework, published in the American Journal of Preventive Cardiology in 2026, provides a standardized, evidence-based roadmap for clinicians to manage heart health across a patient’s lifespan. By integrating tools like the PREVENT™ risk scoring system and addressing Cardiovascular-Kidney-Metabolic (CKM) syndrome, the framework shifts clinical focus toward early, … Read more
The Unexpected Benefit of Aspirin: Unmasking Silent Bladder Cancer For millions of people, a daily low-dose aspirin is a cornerstone of heart health, primarily used to prevent blood clots. However, new research published in the Journal of Internal Medicine suggests this common medication might be performing a hidden, life-saving service: acting as an early warning … Read more